Furoshine-SB Injection is a potent combination antibiotic formulation containing Cefuroxime 1500mg and Sulbactam 750mg, designed to combat a broad spectrum of bacterial infections. Cefuroxime, a second-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while Sulbactam acts as a beta-lactamase inhibitor, enhancing the efficacy of Cefuroxime by preventing enzymatic degradation by resistant bacteria. This synergistic action makes Furoshine-SB highly effective against various gram-positive and gram-negative pathogens, including strains producing beta-lactamase enzymes. It is commonly indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and septicemia. Administered via intramuscular or intravenous injection, Furoshine-SB ensures rapid and effective drug delivery, suitable for moderate to severe infections. Dosage and duration should be determined by a healthcare professional based on the severity of infection, patient condition, and microbial sensitivity. Common side effects may include local injection site reactions, gastrointestinal disturbances, and hypersensitivity reactions. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Proper medical supervision is essential to maximize therapeutic benefits and minimize potential adverse effects.